Acute Ischaemic Stroke Clinical Trial
Official title:
A Phase III Trial to Assess the Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset
This is a randomized, rt-PA controlled, open-label phase 3 clinical study to evaluate the efficacy and safety of recombinant human urokinase(rhPro-UK) versus rt-PA thrombolysis for patients with acute ischaemic stroke in 4.5 hours after stroke onset.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03463551 -
Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic
|
Phase 2 | |
Completed |
NCT02164357 -
Efficacy and Security of an Endovascular Treatment as First Choice Procedure Compared With a Standard Intravenous Thrombolytic Therapy Treatment for Patients With Acute Ischemic Stroke Within 4.5 Hours After Onset
|
N/A | |
Recruiting |
NCT01207336 -
Combined tDCS+PNS After Acute Stroke
|
Phase 2/Phase 3 | |
Completed |
NCT03328403 -
Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion
|
N/A | |
Recruiting |
NCT06379464 -
Screening of New Markers of Gut Microbiota in Stroke and Depression: a Cross-sectional Study
|
||
Completed |
NCT03971526 -
Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke
|
||
Recruiting |
NCT03639922 -
Imatinib in Acute Ischaemic Stroke
|
Phase 3 | |
Completed |
NCT03865225 -
Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT03354429 -
THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
|
Phase 3 | |
Completed |
NCT01994720 -
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
|
Phase 3 | |
Terminated |
NCT01745692 -
Pragmatic Ischaemic Stroke Thrombectomy Evaluation
|
N/A | |
Completed |
NCT03578822 -
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
|
Phase 3 |